On December 17, 2025, MIRA Pharmaceuticals, Inc. reported that the Compensation Committee approved a short-term incentive payout of $242,258 for CEO Erez Aminov, along with a transaction advisory award of $915,000 for acquiring SKNY Pharmaceutical, Inc., recognizing significant progress in 2025.